Shandong Weigao Group Medical Polymer Company Limited
Symbol: SHWGF
PNK
0.9575
USDMarket price today
15.4080
P/E Ratio
0.0000
PEG Ratio
4.33B
MRK Cap
- 0.02%
DIV Yield
Shandong Weigao Group Medical Polymer Company Limited (SHWGF) Financial Statements
Balance Sheet
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1140.1 | 1157.2 | 1238.3 | |||||
balance-sheet.row.short-term-investments | 0 | 48.6 | 71.2 | 68.3 | |||||
balance-sheet.row.net-receivables | 0 | 1039.3 | 1016.6 | 963.4 | |||||
balance-sheet.row.inventory | 0 | 351.7 | 332.8 | 279.5 | |||||
balance-sheet.row.other-current-assets | 0 | 95.6 | 93.4 | 69.3 | |||||
balance-sheet.row.total-current-assets | 0 | 2626.7 | 2600 | 2550.5 | |||||
balance-sheet.row.property-plant-equipment-net | 0 | 1034 | 1051 | 1055.1 | |||||
balance-sheet.row.goodwill | 0 | 525.5 | 523 | 525.2 | |||||
balance-sheet.row.intangible-assets | 0 | 1507.3 | 770.5 | 807.4 | |||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 5235.1 | 1293.4 | 1332.6 | |||||
balance-sheet.row.long-term-investments | 0 | 309.5 | 316.4 | 346.4 | |||||
balance-sheet.row.tax-assets | 0 | 29.2 | 22.9 | 24.6 | |||||
balance-sheet.row.other-non-current-assets | 0 | -4488.3 | -512.8 | -512.8 | |||||
balance-sheet.row.total-non-current-assets | 0 | 2119.5 | 2171 | 2245.9 | |||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.total-assets | 0 | 4746.2 | 4771 | 4796.4 | |||||
balance-sheet.row.account-payables | 0 | 163.2 | 207.3 | 203.2 | |||||
balance-sheet.row.short-term-debt | 0 | 449 | 182.4 | 150 | |||||
balance-sheet.row.tax-payables | 0 | 33.8 | 25.7 | 23.6 | |||||
balance-sheet.row.long-term-debt-total | 0 | 210.8 | 488.3 | 542 | |||||
Deferred Revenue Non Current | 0 | 1.4 | 1.1 | 0.5 | |||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||
balance-sheet.row.other-current-liab | 0 | 396.8 | 410 | 409.2 | |||||
balance-sheet.row.total-non-current-liabilities | 0 | 286.9 | 538.3 | 668.5 | |||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.capital-lease-obligations | 0 | 14.2 | 15 | 9.1 | |||||
balance-sheet.row.total-liab | 0 | 1355.7 | 1391.3 | 1480.7 | |||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.common-stock | 0 | 64.4 | 65.7 | 71.7 | |||||
balance-sheet.row.retained-earnings | 0 | 2625.8 | 2475.7 | 2381.5 | |||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 87.6 | 178.7 | 160.6 | |||||
balance-sheet.row.other-total-stockholders-equity | 0 | 386.7 | 394.2 | 430.3 | |||||
balance-sheet.row.total-stockholders-equity | 0 | 3164.5 | 3114.3 | 3044.1 | |||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 4746.2 | 4771 | 4796.4 | |||||
balance-sheet.row.minority-interest | 0 | 217.6 | 255.5 | 257.3 | |||||
balance-sheet.row.total-equity | 0 | 3382.1 | 3369.8 | 3301.4 | |||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||
Total Investments | 0 | 358.1 | 387.6 | 414.7 | |||||
balance-sheet.row.total-debt | 0 | 674 | 685.6 | 701.1 | |||||
balance-sheet.row.net-debt | 0 | -417.6 | -400.4 | -468.9 |
Cash Flow Statement
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 405.4 | 351.7 | 302.4 | ||||
cash-flows.row.depreciation-and-amortization | 0 | 118.9 | 113 | 102.2 | ||||
cash-flows.row.deferred-income-tax | 0 | -469.7 | -381.9 | -294.9 | ||||
cash-flows.row.stock-based-compensation | 0 | 91.8 | 76.5 | 30.7 | ||||
cash-flows.row.change-in-working-capital | 0 | -158.8 | -38.1 | -30.3 | ||||
cash-flows.row.account-receivables | 0 | -124.1 | -40.2 | -106.1 | ||||
cash-flows.row.inventory | 0 | -80.2 | -27.9 | -37.9 | ||||
cash-flows.row.account-payables | 0 | 64.1 | -11.2 | 84.1 | ||||
cash-flows.row.other-working-capital | 0 | -18.6 | 41.3 | 29.6 | ||||
cash-flows.row.other-non-cash-items | 0 | 341 | 337.5 | 281.5 | ||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -166.2 | -180.2 | -146 | ||||
cash-flows.row.acquisitions-net | 0 | 4.9 | 219.6 | -19.6 | ||||
cash-flows.row.purchases-of-investments | 0 | -247.2 | -5.9 | -27.6 | ||||
cash-flows.row.sales-maturities-of-investments | 0 | 0.1 | 0.6 | 0.1 | ||||
cash-flows.row.other-investing-activites | 0 | 0 | 0.5 | 216.9 | ||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -408.3 | 34.6 | 23.8 | ||||
cash-flows.row.debt-repayment | 0 | -13.9 | -30.5 | -151.3 | ||||
cash-flows.row.common-stock-issued | 0 | -35.2 | 40.4 | 37.5 | ||||
cash-flows.row.common-stock-repurchased | 0 | -5.2 | -11.3 | -1.9 | ||||
cash-flows.row.dividends-paid | 0 | -110.4 | -101 | -101.6 | ||||
cash-flows.row.other-financing-activites | 0 | 40.3 | -176.3 | 10.5 | ||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -124.5 | -278.7 | -206.9 | ||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 96.2 | -54.4 | -57 | ||||
cash-flows.row.net-change-in-cash | 0 | -84 | 251.7 | 263.1 | ||||
cash-flows.row.cash-at-end-of-period | 0 | 1086 | 1170 | 918.3 | ||||
cash-flows.row.cash-at-beginning-of-period | 0 | 1170 | 918.3 | 655.2 | ||||
cash-flows.row.operating-cash-flow | 0 | 328.6 | 458.7 | 391.6 | ||||
cash-flows.row.capital-expenditure | 0 | -166.2 | -180.2 | -146 | ||||
cash-flows.row.free-cash-flow | 0 | 162.4 | 278.5 | 245.6 |
Income Statement Row
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1871.6 | 2027.3 | 2041.4 | |||||
income-statement-row.row.cost-of-revenue | 0 | 970.9 | 1005.8 | 942.3 | |||||
income-statement-row.row.gross-profit | 0 | 900.7 | 1021.6 | 1099.1 | |||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||
income-statement-row.row.research-development | 0 | - | - | - | |||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.other-expenses | 0 | 6.6 | 10.3 | 10.9 | |||||
income-statement-row.row.operating-expenses | 0 | 581.1 | 566.3 | 622.9 | |||||
income-statement-row.row.cost-and-expenses | 0 | 1552 | 1572 | 1565.2 | |||||
income-statement-row.row.interest-income | 0 | 235.7 | 26.8 | 22.4 | |||||
income-statement-row.row.interest-expense | 0 | 273 | 28.5 | 21.7 | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.total-other-income-expensenet | 0 | 4.7 | 27.4 | -42.1 | |||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||
income-statement-row.row.other-operating-expenses | 0 | 6.6 | 10.3 | 10.9 | |||||
income-statement-row.row.total-operating-expenses | 0 | 4.7 | 27.4 | -42.1 | |||||
income-statement-row.row.interest-expense | 0 | 273 | 28.5 | 21.7 | |||||
income-statement-row.row.depreciation-and-amortization | 0 | 128.2 | 118.9 | 113 | |||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||
income-statement-row.row.operating-income | 0 | 319.6 | 455.3 | 476.1 | |||||
income-statement-row.row.income-before-tax | 0 | 324.3 | 482.7 | 434 | |||||
income-statement-row.row.income-tax-expense | 0 | 43.5 | 63.2 | 64.9 | |||||
income-statement-row.row.net-income | 0 | 283.2 | 405.4 | 351.7 |
Frequently Asked Question
What is Shandong Weigao Group Medical Polymer Company Limited (SHWGF) total assets?
Shandong Weigao Group Medical Polymer Company Limited (SHWGF) total assets is 4746213417.000.
What is enterprise annual revenue?
The annual revenue is N/A.
What is firm profit margin?
Firm profit margin is 0.482.
What is company free cash flow?
The free cash flow is 0.075.
What is enterprise net profit margin?
The net profit margin is 0.152.
What is firm total revenue?
The total revenue is 0.168.
What is Shandong Weigao Group Medical Polymer Company Limited (SHWGF) net profit (net income)?
The net profit (net income) is 283215434.000.
What is firm total debt?
The total debt is 674011810.000.
What is operating expences number?
The operating expences are 581122121.000.
What is company cash figure?
Enretprise cash is 0.000.